People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Other Health Care, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HistoSonics, Inc. | — | Other Health Care | Series D+ | $308.2M | $1.0B | 2018 |
| Videri Inc. | — | Other Technology | Series B | $45.8M | $761.4M | 2013 |
| Augustine Temperature Management LLC | — | Other Health Care | Series A | $20.1M | $201.8M | 2017 |
| Gila Therapeutics, Inc. | — | Biotechnology | Seed | $6.2M | $2.7M | 2021 |
| EmboMedics, Inc. | — | Biotechnology | Series A | $5.9M | $26.8M | 2014 |
Jon Freeman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jon Freeman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Cohen | 1 | 11 |
| Timothy Barberich | 1 | 6 |
| Praveen Tyle | 1 | 5 |
| V. Kadir Kadhiresan | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Linda Tufts | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Michael Blue | 1 | 4 |
| Robert Stevens | 1 | 4 |
| Kadir Kadhiresan | 1 | 4 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Gerald Mattys | 1 | 3 |
| Andrew Von Eschenbach | 1 | 3 |
| John Keating | 1 | 3 |
| Reza Malek | 1 | 3 |
| Wen Chen | 1 | 3 |
| Scott D. Augustine | 1 | 2 |
| Jim Adox | 1 | 2 |
| Akhil Tripathi | 1 | 2 |
| Robert Morff | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.